Drug Type Recombinant protein |
Synonyms CTX 114, CTX-114, CTX114 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Character Biosciences, Inc.Startup |
Active Organization Character Biosciences, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Geographic Atrophy | Preclinical | US | Character Biosciences, Inc.Startup | 06 May 2024 |